MED12 and benign neoplasm: Genomic driver alterations are identifiable in many benign neoplasms; for instance, uterine leiomyomas harbor recurrent MED12 mutations as well as complex chromosomal rearrangements23,24, and profiling of hepatocellular adenomas has revealed multiple recurrent mutations22.